Price targets set by research firms often influence investor sentiment and can lead to changes in the stock's price. In this case, Zacks Small-Cap Research's $40 price valuation for Lipocine Inc. is likely to be seen as a positive signal by investors, potentially leading to an increase in the stock's price in the short term.